Filtered By:
Specialty: Primary Care
Condition: Bleeding

This page shows you your search results in order of date. This is page number 4.

Order by Relevance | Date

Total 63 results found since Jan 2013.

Dual Antiplatelet Therapy Is Superior to Aspirin in Preventing Short-Term Recurrent Stroke at the Cost of More Major Bleeding
Am Fam Physician. 2021 Nov 1;104(5):Online.NO ABSTRACTPMID:34783507
Source: American Family Physician - November 16, 2021 Category: Primary Care Authors: Henry C Barry Source Type: research

The use and adherence of oral anticoagulants in Primary Health Care in Catalunya, Spain: A real-world data cohort study.
CONCLUSIONS: Acenocoumarol was the most frequently prescribed OAC as first therapy in NVAF patients. Non-naive to DOAC showed better persistence than naive. Rivaroxaban showed higher proportion of adherent patients during the implementation phase than apixaban and dabigatran the lowest. PMID: 32788057 [PubMed - as supplied by publisher]
Source: Atencion Primaria - August 8, 2020 Category: Primary Care Authors: Giner-Soriano M, Cortes J, Gomez-Lumbreras A, Prat-Vallverdú O, Quijada-Manuitt MA, Morros R Tags: Aten Primaria Source Type: research

Anticoagulation: Updated Guidelines for Outpatient Management.
Abstract Anticoagulation therapy is recommended for preventing, treating, and reducing the recurrence of venous thromboembolism, and preventing stroke in persons with atrial fibrillation. Direct oral anticoagulants are first-line agents for eligible patients for treating venous thromboembolism and preventing stroke in those with nonvalvular atrial fibrillation. Vitamin K antagonists are recommended for patients with mechanical valves and valvular atrial fibrillation. Vitamin K antagonists inhibit the production of vitamin K-related factors and require a minimum of five days overlap with parenteral anticoagulants, ...
Source: American Family Physician - September 30, 2019 Category: Primary Care Authors: Wigle P, Hein B, Bernheisel CR Tags: Am Fam Physician Source Type: research

More Bleeding on NOACs Seen in Kidney Disease? (CME/CE)
(MedPage Today) -- Stroke prevention similar to warfarin in observational study
Source: MedPage Today Primary Care - July 12, 2018 Category: Primary Care Source Type: news

Afib Post-Stroke OAC Tied to Fewer Long-Term Events
(MedPage Today) -- No increased risk of bleeding complications in Danish registry
Source: MedPage Today Primary Care - May 18, 2018 Category: Primary Care Source Type: news

When hormonal treatment is not an option
An integrated analysis of safety data from seven Phase 2/3 double-blind, placebo-controlled trials has been conducted for ospemifene (Senshio ®). Adverse drug reactions are well characterized, benign and not unexpected from a SERM used for the treatment of VVA (i.e. hot flushes, leg cramps). There is no evidence to date that ospemifene leads to an increase in vaginal bleeding, endometrial hyperplasia or cancer; VTE, stroke or other cardi ovascular events; or any other adverse event of special interest.
Source: Maturitas - February 14, 2018 Category: Primary Care Authors: Felix Lugo Source Type: research

Recurrent Ischemic Stroke: Strategies for Prevention.
Abstract Recurrent strokes make up almost 25% of the nearly 800,000 strokes that occur annually in the United States. Risk factors for ischemic stroke include hypertension, diabetes mellitus, hyperlipidemia, sleep apnea, and obesity. Lifestyle modifications, including tobacco cessation, decreased alcohol use, and increased physical activity, are also important in the management of patients with a history of stroke or transient ischemic attack. Antiplatelet therapy is recommended to reduce the risk of recurrent ischemic stroke. The selection of antiplatelet therapy should be based on timing, safety, effectiveness, ...
Source: American Family Physician - October 1, 2017 Category: Primary Care Authors: Oza R, Rundell K, Garcellano M Tags: Am Fam Physician Source Type: research

Post-Stroke Antiplatelet Bleeding Risk Estimated in New Model (CME/CE)
(MedPage Today) -- But 10-item score may need better accuracy before heading to clinic
Source: MedPage Today Primary Care - August 2, 2017 Category: Primary Care Source Type: news

The role of contraindications in prescribing anticoagulants to patients with atrial fibrillation: a cross-sectional analysis of primary care data in the UK.
CONCLUSION: The presence or absence of recorded contraindications has little influence on the decision to prescribe anticoagulants for the prevention of stroke in patients with AF. The study analysis suggests that, nationally, 38 000 patients with AF with contraindications are treated with anticoagulants. This has implications for patient safety. PMID: 28630059 [PubMed - as supplied by publisher]
Source: The British Journal of General Practice - June 19, 2017 Category: Primary Care Authors: Adderley N, Ryan R, Marshall T Tags: Br J Gen Pract Source Type: research

Aspirin for Primary Prevention
Aspirin reduces the risk of nonfatal myocardial infarction and stroke, and the risk of colorectal cancer. Aspirin increases the risk of gastrointestinal and intracranial bleeding. The best available evidence supports initiating aspirin in select populations. In 2016, the US Preventive Services Task Force recommended initiating aspirin for the primary prevention of both cardiovascular disease and colorectal cancer among adults ages 50 to 59 who are at increased risk for cardiovascular disease. Adults 60 to 69 who are at increased cardiovascular disease risk may also benefit. There remains considerable uncertainty about whet...
Source: Medical Clinics of North America - June 1, 2017 Category: Primary Care Authors: Ilana B. Richman, Douglas K. Owens Source Type: research

Diagnosis and Treatment of Atrial Fibrillation.
Abstract Atrial fibrillation is a supraventricular arrhythmia that adversely affects cardiac function and increases the risk of stroke. It is the most common arrhythmia and a major source of morbidity and mortality; its prevalence increases with age. Pulse rate is sensitive, but not specific, for diagnosis, and suspected atrial fibrillation should be confirmed with 12-lead electrocardiography. Because normal electrocardiographic findings do not rule out atrial fibrillation, home monitoring is recommended if there is clinical suspicion of arrhythmia despite normal test results. Treatment is based on decisions made ...
Source: American Family Physician - September 14, 2016 Category: Primary Care Authors: Gutierrez C, Blanchard DG Tags: Am Fam Physician Source Type: research

Pharmacologic Therapies in Anticoagulation
This article reviews the pharmacology of the main anticoagulant classes (vitamin K antagonists, direct oral anticoagulants, and heparins) and their clinical indications based on evidence-based data currently available in the literature.
Source: Medical Clinics of North America - May 26, 2016 Category: Primary Care Authors: Joana Lima Ferreira, Joyce E. Wipf Source Type: research

New oral anticoagulants for nonvalvular atrial fibrillation in the elderly: Limited applicability in primary care.
CONCLUSION: There is uncertainty about effectiveness and safety of NOACs in unselected elderly patients with AF in primary care. Therefore, the balance between benefit and harm is still unclear. For this reason, routine use of NOACs is not recommended in elderly patients in primary care. PMID: 25495417 [PubMed - in process]
Source: European Journal of General Practice - December 4, 2015 Category: Primary Care Tags: Eur J Gen Pract Source Type: research

New oral anticoagulants for patients with nonvalvular atrial fibrillation
This article reviews the new drugs.
Source: Journal of the American Academy of Physician Assistants - October 27, 2015 Category: Primary Care Tags: CME: Cardiology Source Type: research